Shopping in Denver? Bring a bag or pay up | Colorado Springs News

Shopping in Denver? Bring a bag or pay up | Colorado Springs News Denver shoppers will have to bring their own bags or face a…

View More Shopping in Denver? Bring a bag or pay up | Colorado Springs News

Roche: Actemra/RoActemra Gets FDA Emergency-Use Authorization for Covid-19 Treatment

Roche: Actemra/RoActemra Gets FDA Emergency-Use Authorization for Covid-19 Treatment By Kim Richters Roche Holding AG said Friday that it has received an emergency-use authorization from…

View More Roche: Actemra/RoActemra Gets FDA Emergency-Use Authorization for Covid-19 Treatment

Lilly to seek FDA approval for potential Alzheimer’s drug later this year

Lilly to seek FDA approval for potential Alzheimer’s drug later this year INDIANAPOLIS — Eli Lilly is nearly ready to take another shot at getting…

View More Lilly to seek FDA approval for potential Alzheimer’s drug later this year

Arcus Biosciences Reports Positive Results From Trial for Lung Cancer Treatment

Arcus Biosciences Reports Positive Results From Trial for Lung Cancer Treatment By Chris Wack Arcus Biosciences Inc. reported positive results from the first interim analysis…

View More Arcus Biosciences Reports Positive Results From Trial for Lung Cancer Treatment

Medical Device Maker CVRx to Go Public Next Week

Medical Device Maker CVRx to Go Public Next Week Text size Andrei Rahalski/Dreamstime CVRx, the medical device maker backed by Johnson & Johnson, will list…

View More Medical Device Maker CVRx to Go Public Next Week

Moderna and Other Vaccine Makers Are Dropping. Here’s Why.

Moderna and Other Vaccine Makers Are Dropping. Here’s Why. Text size A man receives the Moderna Covid-19 inoculation at a newly-opened vaccination centre inside Nagoya…

View More Moderna and Other Vaccine Makers Are Dropping. Here’s Why.

GlaxoSmithKline Expects Long-Term Sales, Profit Growth, Driven by Vaccines and Specialty Medicines — Update

GlaxoSmithKline Expects Long-Term Sales, Profit Growth, Driven by Vaccines and Specialty Medicines — Update –GlaxoSmithKline expects sales, profit growth in the next five years, driven…

View More GlaxoSmithKline Expects Long-Term Sales, Profit Growth, Driven by Vaccines and Specialty Medicines — Update